Quinonoid and phenazine compounds: Synthesis and evaluation against H37Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis

Quinonoid and phenazine compounds: Synthesis and evaluation against H37Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis Design of hybrid molecules as antimycobacterial compounds: Synthesis of isoniazid-naphthoquinone derivatives and their activity against susceptible and resistant strains of Mycobacterium tuberculosis Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents Quinolone-isoniazid hybrids: synthesis and preliminary in vitro cytotoxicity and anti-tuberculosis evaluation Synthesis of isonicotinic acid N′-arylidene-N-[2-oxo-2-(4-aryl-piperazin-1-yl)-ethyl]-hydrazides as antituberculosis agents Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives Structure−Activity Relationships for a Series of Quinoline-Based Compounds Active against Replicating and NonreplicatingMycobacterium tuberculosis Synthesis and in vitro antitubercular activity of a series of quinoline derivatives Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines